Limiting Factors in Implementing Pharmacovigilance Principles in the Elderly.

Area of Science:

• Geriatric pharmacology
• Medication safety
• Pharmacovigilance in elderly populations

Background:

• The elderly population presents unique challenges for medication safety and efficacy.
• Physiological changes, polypharmacy, and concurrent use of herbal medicines increase adverse drug event (ADE) risk in older adults.
• Multimorbidity and complex regimens contribute to inappropriate prescribing and non-adherence.

Purpose of the Study:

• To highlight the limitations in current pharmacovigilance practices concerning the elderly.
• To underscore the heightened risk of ADEs in the aging demographic.
• To emphasize the need for tailored strategies to ensure safe and effective medication use in older patients.

Main Methods:

• Review of existing literature on pharmacovigilance challenges in the elderly.
• Analysis of factors contributing to ADEs in older adults, including physiological changes, polypharmacy, and herbal medicine interactions.
• Discussion of clinical trial limitations and their impact on real-world evidence.

Main Results:

• Elderly patients are predisposed to harmful drug events due to altered drug metabolism and increased drug-drug interactions.
• Complex medication regimens in multimorbid elderly patients often lead to inappropriate prescribing and poor adherence.
• Exclusion of elderly individuals in clinical trials creates a gap between trial data and real-world patient outcomes.

Conclusions:

• Current pharmacovigilance frameworks are insufficient to address the complexities of medication use in the elderly.
• The growing elderly population faces significant risks of ADEs, necessitating improved clinical decision-making and tailored safety monitoring.
• Addressing these challenges is crucial for optimizing therapeutic outcomes and ensuring the well-being of older patients.